findmyKOL
Clinical trialNCT05846789RecruitingPhase 2Interventional

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

SponsorKathy MillerEnrollment168Estrogen-receptor-low Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Emory University

    Atlanta, Georgia, United States

    Shipra Gandhi, MD
    Recruiting
  • Iu Health Joe and Shelly Schwarz Cancer Center

    Carmel, Indiana, United States

    Recruiting
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana, United States

    Kathy Miller, MD
    Recruiting
  • Sidney and Lois Eskenazi Hospital

    Indianapolis, Indiana, United States

    Recruiting
  • Roswell Park Comprehensive Cancer Center

    Buffalo, New York, United States

    Sheheryar Kabraji, MD
    Recruiting
  • Duke University

    Durham, North Carolina, United States

    Alexandra Thomas, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jul 2024
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
8 May 2026
Registered enrollment
168
Registry id
NCT05846789
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.